2 results
Approved WMOPending
The primary objective is to evaluate the safety and efficacy of the PulseCath during support of patients with impaired ventricular function, for a period between 24 hours minimum and 14 days maximum. Safety will be assessed by the incidence of…
Approved WMORecruiting
Transcutaneous auricular vagal nerve stimulation (taVNS) has been recently shown to have analgesic potential in patients with chronic functional abdominal (visceral) pain. Functional abdominal pain, as commonly seen in conditions such as irritable…